Neurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivo.
We recently reported that AAV1-Rheb(S16H) transduction could protect hippocampal neurons through the induction of BDNF in the rat hippocampus in vivo. However, it is still unclear how neuronal BDNF produced by AAV1-Rheb(S16H) transduction induces neuroprotective effects in the hippocampus and whether its upregulation contributes to the construction of a neuroprotective system in the adult brain. To determine the presence of a neuroprotective system in the hippocampus of patients with Alzheimer's disease (AD), we examined the levels of GFAP, BDNF and CNTF, and their respective receptors TrkB and CNTFRα in the hippocampus of AD patients. In addition, we determined whether AAV1-Rheb(S16H) transduction stimulates astroglial activation and whether reactive astrocytes contribute to neuroprotection in models of hippocampal neurotoxicity in vivo and in vitro. Our results showed that AD patients may have a potential neuroprotective system, demonstrated by increased levels of full-length TrkB and CNTFRα in the hippocampus, and that AAV1-Rheb(S16H) transduction induced the sustained increases in the levels of full-length TrkB and CNTFRα in reactive astrocytes and hippocampal neurons, respectively. Moreover, neuronal BDNF produced by Rheb(S16H) transduction of hippocampal neurons induced reactive astrocytes, resulting in CNTF production through the activation of astrocytic TrkB, and the upregulation of neuronal BDNF and astrocytic CNTF had synergistic effects on the survival of hippocampal neurons in vivo. The results demonstrated that Rheb(S16H) transduction of hippocampal neurons could strengthen the neuroprotective system, and the intensified system may have a therapeutic value against neurodegeneration in the adult brain.